Epicrispr Biotechnologies vs ONWARD Medical
Epicrispr Biotechnologies vs ONWARD Medical, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and ONWARD Medical on 50/100.
Where each one leads
Epicrispr Biotechnologies
- our overall score: 62/100 against 50/100
- domain rating: 40/100 against 3/100
ONWARD Medical
- agent readiness: 50/100 against 39/100
- funding raised: $171M against $90.0M
At a glance
| Measure | Epicrispr Biotechnologies | ONWARD Medical |
|---|---|---|
| What it is | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). | NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries. |
| Category | Biotechnology, Therapeutics, Rare Diseases, Epigenetics | Biotechnology, Medical Devices, Neurotechnology, Healthcare |
| Sells toBusiness model | B2B | B2B2C |
| Offering | Platform | Hardware |
| Founded | 2020 | 2015 |
| Headquarters | South San Francisco, United States | Eindhoven, Netherlands |
| Status | Active | Active |
Size, funding and growth
| Measure | Epicrispr Biotechnologies | ONWARD Medical |
|---|---|---|
| Employees | 51 | Not published |
| Total funding | $90.0M | $171M |
| Latest round | Series C | Private Placement |
| LinkedIn followers | 7,025 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Epicrispr Biotechnologies | ONWARD Medical |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 50/100 |
| Traction | 57/100 | 40/100 |
| Team | 40/100 | 70/100 |
| Search visibility | 20/100 | 15/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 3/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Epicrispr Biotechnologies | ONWARD Medical |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Not detected |
| Analytics | Google Analytics 4 | Not detected |
Epicrispr Biotechnologies vs ONWARD Medical: common questions
Which is better, Epicrispr Biotechnologies or ONWARD Medical?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Epicrispr Biotechnologies and ONWARD Medical compare on the numbers?
Epicrispr Biotechnologies leads on our overall score (62/100 against 50/100), domain rating (40/100 against 3/100). ONWARD Medical leads on agent readiness (50/100 against 39/100), funding raised ($171M against $90.0M).
Read the full Epicrispr Biotechnologies review and pricing or the ONWARD Medical review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.